Small molecule drugs are organic compounds with defined chemical structures and molecular weights typically ranging from 500 to 900 Daltons. Unlike biologics, these compounds can easily diffuse across cell membranes to reach intracellular sites and are designed to modulate a specific target that controls the biological processes associated with a specific disease. Increased investments in… Continue reading Rising Demand for Pharmaceutical Contract Manufacturing Services of Small Molecules
NASH is a severe, progressive liver disease characterized by the accumulation of excessive fat in the liver. It is associated with inflammation, hepatocyte injury and fibro-genesis, and may worsen into fibrosis/cirrhosis, liver failure and rarely into liver cancer. NASH is the second leading cause for liver damage and considered to be the rapidly growing reason… Continue reading Latest Developments in NASH (Nonalcoholic Steatohepatitis) Pipeline.